|
1 Company |
|
1 Product |
|
1 Product |
|
4 Mechanisms of Action |
|
0 Trials |
|
4 News |
|
- | Trial completion, Enrollment change, Trial primary completion date: Presbyopic Supracor Treatment for Near Myopic/Hyperopic Pseudophakic Eyes (clinicaltrials.gov) - May 20, 2015
P4, N=33, Completed, Sponsor: Technolas Perfect Vision GmbH
Recruiting --> Completed | N=45 --> 33 | Trial primary completion date: Jan 2012 --> Oct 2013
- loteprednol etabonate / Generic mfg.
Enrollment closed, Surgery: Clinical Outcomes and Evaluation of Lotemax 0.5% in Treatment of Ocular Inflammation Associated With Cataract Surgery (clinicaltrials.gov) - Apr 15, 2013
P=N/A, N=100, Active, not recruiting, Sponsor: Discover Vision Centers
Recruiting --> Completed | N=45 --> 33 | Trial primary completion date: Jan 2012 --> Oct 2013 Recruiting --> Active, not recruiting
- | Trial completion: The Effects of BAK on the Blood Aqueous Barrier of Pseudophakic Patients (clinicaltrials.gov) - Jul 11, 2012
P4, N=44, Completed, Sponsor: University of Campinas, Brazil
Recruiting --> Active, not recruiting Not yet recruiting --> Completed